Article

Comparison of 10 emerging SARS-CoV-2 Variants: infectivity, animal tropism, and antibody neutralization

2021-05-06

Abstract excerpt

Ten emerging SARS-CoV-2 variants—B.1.1.298, B.1.1.7, B.1.351, P.1, P.2, B.1.429, B.1.525, B.1.526-1, B.1.526-2, B.1.1.318—and seven corresponding single amino acid mutations in the receptor-binding domain were examined using SARS-CoV-2 pseudovirus. The results indicate that the current SARS-CoV-2 variants do not increase infectivity among humans. The K417N/T, N501Y, or E484K-carrying variants exhibited increased a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 85722b5e-c24f-54d8-a372-f9d1afa3319b
DOI: 10.21203/rs.3.rs-492659/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of 10 emerging SARS-CoV-2 Variants: infectivity, animal tropism, and antibody neutralizationDOI 10.21203/rs.3.rs-492659/v1Read

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.Semantic proximity Read

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsSemantic proximity Read

Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.Semantic proximity Read

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodiesSemantic proximity Read

Infectivity and antigenicity of SARS-CoV-2 B.1.617 variantsSemantic proximity Read

Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity.Semantic proximity Read

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variantsSemantic proximity Read

Neutralization of European, South African, and United States SARS-CoV-2 mutants by a human antibody and antibody domainsSemantic proximity Read

Second-Generation Antibodies Neutralize Emerging SARS-CoV-2 Variants of ConcernSemantic proximity Read

Risk assessment of SARS-CoV-2 replicating and evolving in animals.Semantic proximity Read

Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.Semantic proximity Read

A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concernSemantic proximity Read